These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 29108424)

  • 21. Circular RNAs promote TRPM3 expression by inhibiting hsa-miR-130a-3p in coronary artery disease patients.
    Pan RY; Liu P; Zhou HT; Sun WX; Song J; Shu J; Cui GJ; Yang ZJ; Jia EZ
    Oncotarget; 2017 Sep; 8(36):60280-60290. PubMed ID: 28947970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a peripheral blood long non-coding RNA (Upperhand) as a potential diagnostic marker of coronary artery disease.
    Li X; Zhao Z; Gao C; Rao L; Hao P; Jian D; Li W; Tang H; Li M
    Cardiol J; 2018; 25(3):393-402. PubMed ID: 29168540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2.
    Dzhoyashvili NA; Efimenko AY; Kochegura TN; Kalinina NI; Koptelova NV; Sukhareva OY; Shestakova MV; Akchurin RS; Tkachuk VA; Parfyonova YV
    J Transl Med; 2014 Dec; 12():337. PubMed ID: 25491476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of gene expression profiles in patients with coronary artery disease, type 2 diabetes, and their coexisting conditions.
    Gong R; Chen M; Zhang C; Chen M; Li H
    Diagn Pathol; 2017 Jun; 12(1):44. PubMed ID: 28595632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiles displayed by peripheral blood mononuclear cells from patients with type 2 diabetes mellitus focusing on biological processes implicated on the pathogenesis of the disease.
    Manoel-Caetano FS; Xavier DJ; Evangelista AF; Takahashi P; Collares CV; Puthier D; Foss-Freitas MC; Foss MC; Donadi EA; Passos GA; Sakamoto-Hojo ET
    Gene; 2012 Dec; 511(2):151-60. PubMed ID: 23036710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein (a) is not significantly associated with type 2 diabetes mellitus: cross-sectional study of 1604 cases and 7983 controls.
    Liu C; Xu MX; He YM; Zhao X; Du XJ; Yang XJ
    Acta Diabetol; 2017 May; 54(5):443-453. PubMed ID: 28132096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling of coronary artery disease and its relation with different severities.
    Kashyap S; Kumar S; Agarwal V; Misra DP; Phadke SR; Kapoor A
    J Genet; 2018 Sep; 97(4):853-867. PubMed ID: 30262697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of High-Level Microarray Analysis Methods in the Context of Result Consistency.
    Chrominski K; Tkacz M
    PLoS One; 2015; 10(6):e0128845. PubMed ID: 26057385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).
    Raj R; Bhatti JS; Badada SK; Ramteke PW
    Diabetes Metab Res Rev; 2015 Oct; 31(7):663-71. PubMed ID: 25470794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.
    Berezin AE; Kremzer AA
    Atherosclerosis; 2013 Aug; 229(2):475-81. PubMed ID: 23880208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk Factors.
    LeBlanc M; Zuber V; Andreassen BK; Witoelar A; Zeng L; Bettella F; Wang Y; McEvoy LK; Thompson WK; Schork AJ; Reppe S; Barrett-Connor E; Ligthart S; Dehghan A; Gautvik KM; Nelson CP; Schunkert H; Samani NJ; ; Ridker PM; Chasman DI; Aukrust P; Djurovic S; Frigessi A; Desikan RS; Dale AM; Andreassen OA
    Circ Res; 2016 Jan; 118(1):83-94. PubMed ID: 26487741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events.
    Saely CH; Rein P; Vonbank A; Huber K; Drexel H
    Int J Cardiol; 2013 Aug; 167(3):776-80. PubMed ID: 22483261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
    Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
    Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus.
    Shemyakin A; Kövamees O; Rafnsson A; Böhm F; Svenarud P; Settergren M; Jung C; Pernow J
    Circulation; 2012 Dec; 126(25):2943-50. PubMed ID: 23183942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma BMP-2 levels are associated with atherosclerosis burden and coronary calcification in type 2 diabetic patients.
    Zhang M; Sara JD; Wang FL; Liu LP; Su LX; Zhe J; Wu X; Liu JH
    Cardiovasc Diabetol; 2015 May; 14():64. PubMed ID: 26003174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism, angiographically defined coronary artery disease and myocardial infarction in patients with type 2 diabetes mellitus.
    Narne P; Ponnaluri KC; Singh S; Siraj M; Ishaq M
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):478-86. PubMed ID: 22679279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Sterol Regulatory Element-Binding Proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study.
    Pérez-Belmonte LM; Moreno-Santos I; Cabrera-Bueno F; Sánchez-Espín G; Castellano D; Such M; Crespo-Leiro MG; Carrasco-Chinchilla F; Alonso-Pulpón L; López-Garrido M; Ruiz-Salas A; Becerra-Muñoz VM; Gómez-Doblas JJ; de Teresa-Galván E; Jiménez-Navarro M
    Int J Med Sci; 2017; 14(3):268-274. PubMed ID: 28367087
    [No Abstract]   [Full Text] [Related]  

  • 40. [Association between SUMO4 polymorphisms and coronary artery disease with and without type 2 diabetes mellitus].
    Pu LM; Nan N; Yang Z; Jin ZN
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Oct; 29(5):596-601. PubMed ID: 23042402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.